2026. Clinicopathologic Characteristics, Pathological Response and Safety Profile of Triple-Negative Breast Cancer (TNBC) Patients: A Retrospective Study in Yogyakarta. Duta Pharma Journal. 6, 1 (June 2026), 114–120. DOI:https://doi.org/10.47701/hy4h0v48.